Skip to main content

Table 2 Subpopulations of Vγ9/Vδ 2 T lymphocytes in BD patients and controls

From: Phenotype and functional changes of Vγ9/Vδ2 T lymphocytes in Behçet's disease and the effect of infliximab on Vγ9/Vδ2 T cell expansion, activation and cytotoxicity

 

Active BD

Inactive BD

Controls

P

CD45RO-CD27+ (%)

7.5 ± 2.25

24 ± 7

28 ± 8

< 0.0001

CD45RO+CD27+ (%)

11 ± 6.44

47 ± 9

49 ± 9

< 0.0001

CD45RO+CD27- (%)

57 ± 13

17.8 ± 9.7

19.2 ± 6.7

< 0.001

CD45RO-CD27- (%)

20 ± 6

8.6 ± 3.8

5.5 ± 5.5

< 0.001

  1. BD, Behçet's disease.